- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06566833
Effectiveness of Different Remineralizing Strategies on the Management of Early Carious Lesions in Primary Teeth
January 27, 2025 updated by: Sarah Khairy, Alexandria University
Effectiveness of Different Remineralizing Strategies on the Management of Early Carious Lesions in Primary Teeth (Randomized Controlled Clinical Trial)
the primary aim of the study is remineralization of early carious lesions in primary teeth using different remineralizing agents of different remineralizing strategies when applied in an intensive mode.
The secondary aim of the study is to compare their antibacterial effect against streptococcus mutans and their effect on reducing the size of the lesions.
Study Overview
Status
Completed
Conditions
Detailed Description
The primary aim of the study is to compare the effect of curodont repair fluoride plus (self-assembling peptide p11-4 with 0.5% sodium fluoride) with MI varnish (casein phosphopeptide amorphous calcium phosphate fluoride) and Colgate fluoride varnish (5% sodium fluoride) in remineralization of early carious lesions in primary anterior teeth.
The study sample is consisted of 66 patients aged 3-6 years old with at least 2 white spot lesions in their primary anterior teeth who are assigned into control group (n=22): colgate fluoride varnish, test group 1(n=22): MI varnish and test group 2 (n=22) :curodont repair fluoride plus.
Each material is applied once every 2 weeks for 3 times (intensive mode of application).
The secondary aim of the study is to determine the antibacterial effect of each material against streptococcus mutans is compared by obtaining a plaque sample at baseline then after application by 48 hours, 1 months and 3 months and culturing using disk diffusion method for determining the log count of streptococcus mutans at each time point.
Another secondary aim is to determine the change in lesion size at baseline and after 6 months and 12 months using standardized photographs with a digital camera.
Study Type
Interventional
Enrollment (Actual)
66
Phase
- Early Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Professor
-
Alexandria, Professor, Egypt
- Karin Dowidar
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- healthy children
- age range 3-6
- at least 2 early carious lesions
Exclusion Criteria:
- Children presenting with special health care needs or undergoing medical treatment for chronic or acute diseases.
- Application of fluoride varnish less than 3 months prior to study treatment.
- Any metabolic disorders affecting bone turnover.
- Concurrent participation in another clinical trial.
- Patients receiving any antibiotic within 1 month prior to plaque sample collection
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: curodont repair fluoride plus
self-assembling peptide (p11-4) with 0.05% sodium fluoride
|
biomimetic remineralizing agent
Other Names:
|
|
Experimental: CPP-ACPF varnish
casein phoshphopeptide amorphous calcium phosphate fluoride (CPP-ACPF )
|
remineralizing agents that acts as a fluoride booster
Other Names:
|
|
Active Comparator: 5 % sodium fluoride varnish
5% sodium fluoride varnish
|
remineralizing agent that is used as a gold standard for remineralization
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessing the remineralization of early carious lesions in primary teeth
Time Frame: 3,6,9 and12 months
|
comparing the remineralization effect of different remineralizing agents both qualitatively by comparing the change in ICDAS -11 criteria and quantitatively by using laser fluorescence scores using kavo DIAGNOdent classic after intensive mode of application of the different remineralizing agents
|
3,6,9 and12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
comparing the change in esthetic appearance of early carious lesion before and after treatment
Time Frame: 12 months
|
comparing the change in lesion size using standardized photographs quantitatively by calculating pixel size of the lesion before treatment and after 6 and 12 months of intensive mode of application of the different remineralizing agents using ImageJ software program for image analysis.
Assessing the esthetic appearance of the lesions will be done subjectively by using a visual analogue scale score from 1 to 7
|
12 months
|
|
comparing the antibacterial effect of different remineralizing agents against streptococcus mutans
Time Frame: 3 months
|
Supragingival plaque samples will be collected at baseline then after 48 hours, 1 months and 3 months of application of the materials in an intensive mode.
log count of streptococcus mutans is determined using disk diffusion method using mitis salivaris agar plates
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: karin dowidar, professor, Faculty of Dentistry, Alexandria University, Egypt
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 15, 2023
Primary Completion (Actual)
October 15, 2024
Study Completion (Actual)
October 15, 2024
Study Registration Dates
First Submitted
August 9, 2024
First Submitted That Met QC Criteria
August 20, 2024
First Posted (Actual)
August 22, 2024
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
January 27, 2025
Last Verified
January 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Stomatognathic Diseases
- Tooth Diseases
- Tooth Demineralization
- Dental Caries
- Calcium-Regulating Hormones and Agents
- Anti-Infective Agents
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Protective Agents
- Chelating Agents
- Sequestering Agents
- Anti-Infective Agents, Local
- Cariostatic Agents
- Calcium
- Fluorides
- Listerine
- Sodium Fluoride
- Caseins
- Fluorides, Topical
Other Study ID Numbers
- 00010556 - IORG 0008839
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
only the results of the primary and secondary outcomes of the study will be published after study completion
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Yes
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on White Spot Lesion
-
Future University in EgyptNot yet recruitingWhite Spot Lesion
-
Mansoura UniversityActive, not recruiting
-
Jordan University of Science and TechnologyActive, not recruitingWhite Spot Lesion of ToothJordan
-
King Abdullah University HospitalJordan University of Science and TechnologyActive, not recruitingWhite Spot LesionJordan
-
Al-Azhar UniversityEnrolling by invitation
-
Texas A&M UniversityCompletedWhite Spot LesionUnited States
-
Izmir Katip Celebi UniversityCompletedRemineralization | White Spot LesionTurkey
-
Cairo UniversityNot yet recruiting
-
Universitat Internacional de CatalunyaCompleted
-
EgymedicalpediaCompleted
Clinical Trials on self assmbling peptide p11-4 combined with 0.05% fluoride
-
October 6 UniversityAl-Azhar University; University of Science and Technology of FujairahRecruitingWhite Spot LesionEgypt
-
Ain Shams UniversityRecruitingDental Caries Tooth Demineralization | Post-Orthodontic Esthetic DefectsEgypt
-
Tanta UniversityNot yet recruiting
-
Ain Shams UniversityCompletedWhite Spot Lesions [Initial Caries] on Smooth Surface of ToothEgypt
-
Hams Hamed AbdelrahmanCompletedWhite Spot LesionEgypt
-
University Medicine GreifswaldCompleted
-
Cairo UniversityNot yet recruiting
-
Kunming Tongren HospitalRecruiting
-
Al-Azhar UniversityNot yet recruiting
-
Cairo UniversityUnknown